Zymeworks enters ATM sales agreement with TD Cowen for at-the-market stock offerings

Zymeworks Inc.

Agreement dated August 2, 2024 with TD Securities (USA) LLC (TD Cowen) as sales agent.
Shares offered via methods permitted under Rule 415(a)(4), including on Nasdaq.
Commission of up to 3.0% of gross proceeds on any shares sold under the agreement.
Company is not obligated to sell any shares and may terminate agreement at any time.
Offered under existing S-3ASR registration statement filed May 2, 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.